Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
360 studies found for:    Amyotrophic Lateral Sclerosis (ALS)
Show Display Options
Rank Status Study
21 Active, not recruiting Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo (for MN-166);   Drug: MN-166
22 Completed A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: TCH346
23 Unknown  Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: Human spinal cord stem cell implantation
24 Recruiting Neuroinflammation in Amyotrophic Lateral Sclerosis - Mechanisms and Therapeutic Perspectives: a Translational Pilot Study Among ALS Patients
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Other: ALS Functional rating Scale-revised (ALS FRS-R);   Other: slow vital capacity;   Other: Blood sample;   Other: Cerebrospinal Fluid (CSF) sample
25 Completed Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo of MCI-186
26 Active, not recruiting A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: E0302 (mecobalamin)
27 Completed A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: E0302 (mecobalamin);   Drug: Placebo
28 Completed Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea
Conditions: Sialorrhea;   Amyotrophic Lateral Sclerosis
Interventions: Drug: Botox injection;   Drug: Placebo injection
29 Unknown  Safety and Tolerability of Anakinra in Combination With Riluzol in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Anakinra
30 Unknown  Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples
Condition: Amyotrophic Lateral Sclerosis
Intervention:
31 Completed Amyotrophic Lateral Sclerosis (ALS) Gulf War Study
Condition: Amyotrophic Lateral Sclerosis
Intervention:
32 Unknown  Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: YAM80
33 Completed Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Rasagiline;   Drug: Placebo
34 Enrolling by invitation HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Raltegravir;   Drug: Zidovudine
35 Enrolling by invitation Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention:
36 Enrolling by invitation Therapeutic Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: Biological: Cell-based therapy
37 Completed Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Resistance Exercise;   Other: Endurance Exercise;   Other: Stretching/Range-of-Motion
38 Not yet recruiting Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Spirit1
39 Recruiting Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Device: Micro Mouth Pressure Meter;   Device: Iowa Oral Performance Instrument;   Device: Electrical Impedance Myography;   Drug: Capsaicin;   Procedure: Videofluoroscopic Swallowing Study;   Procedure: Pulmonary Function Testing;   Other: Swallowing Related Quality of Life Questionnaire;   Other: Functional Oral Intake Scale;   Other: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised;   Other: Eating Assessment Tool-10;   Other: Communicative Effectiveness Survey;   Other: The Center for Neurologic Studies Bulbar Function Scale
40 Completed Muscle Training of Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: Muscle training

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.